326
Views
13
CrossRef citations to date
0
Altmetric
Original Research

Development of a Standardized Scoring System to Assess a Murine Model of Clostridium difficile Colitis

, , , , , , & show all

References

  • Rupnik M, Wilcox MH, Gerding DN. Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat Rev Microbiol. 2009;7(7):526–536.
  • Burke KE, Lamont JT. Clostridium difficile infection: a worldwide disease. Gut Liver. 2014;8(1):1–6.
  • Voth DE, Ballard JD. Clostridium difficile toxins: mechanism of action and role in disease. Clin Microbiol Rev. 2005;18(2):247–263.
  • Leffler DA, Lamont JT. Clostridium difficile infection. N Engl J Med. 2015;372(16):1539–1548.
  • Hasegawa M, Yamazaki T, Kamada N, et al. Nucleotide-binding oligomerization domain 1 mediates recognition of Clostridium difficile and induces neutrophil recruitment and protection against the pathogen. J Immunol. 2011;186(8):4872–4880.
  • Koon HW, Ho S, Hing T, et al. Fidaxomicin inhibits Clostridium difficile toxin A-mediated enteritis in the mouse ileum. Antimicrob Agents Chemother. 2014;58(8):4642–4650.
  • Girinathan BP, Braun S, Sirigireddy AR, et al. Importance of glutamate dehydrogenase (GDH) in Clostridium difficile colonization in vivo. PLOS One. 2016;11(7):e0160107.
  • Czuprynski CJ, Johnson WJ, Balish E, et al. Pseudomembranous colitis in Clostridium difficile-monoassociated rats. Infect Immun. 1983;39:1368–1376.
  • Peng Z, Ling L, Stratton CW, et al. Advances in the diagnosis and treatment of Clostridium difficile infections. Emerg Microbes Infect. 2018;7(1):15
  • Fekety R, Silva J, Toshniwal R, et al. Antibiotic-associated colitis: effects of antibiotics on Clostridium difficile and the disease in hamsters. Rev Infect Dis.1979;1(2):386–397.
  • Knoop FC. Clindamycin-associated enterocolitis in guinea pigs: evidence for a bacterial toxin. Infect Immun. 1979;23(1):31–33.
  • Vaishnavi C. Clinical spectrum & pathogenesis of Clostridium difficile associated diseases. Indian J Med Res. 2010;131:487–499.
  • Wilson KH, Sheagren JN, Freter R, et al. Gnotobiotic models for study of the microbial ecology of Clostridium difficile and Escherichia coli. J Infect Dis. 1986;153(3):547–551.
  • Chen X, Katchar k, Goldsmith J, et al. A mouse model of Clostridium difficile-associated disease. Gastroenterology. 2008;135(6):1984–1992.
  • Sodhi C, Richardson W, Gribar S, Hackam DJ. The development of animal models for the study of necrotizing enterocolitis. Dis Models Mech. 2008;1(2–3):94–98.
  • Collins J, Auchtung JM, Schaefer L, Eaton KA, Britton RA. Humanized microbiota mice as a model of recurrent Clostridium difficile disease . Microbiome. 2015;3:35.
  • Julia V, McSorley SS, Malherbe L, et al. Priming by microbial antigens from the intestinal flora determines the ability of CD4+ T cells to rapidly secrete IL-4 in BALB/c mice infected with Leishmania major. J Immunol. 2000;165(10):5637–5645.
  • Hutton ML, Mackin KE, Chakravorty A, Lyras D. Small animal models for the study of Clostridium difficile disease pathogenesis. FEMS Microbiol Lett. 2014;352(2):140–149.
  • Riegler G, Esposito I. Bristol scale stool form. a still valid help in medical practice and clinical research. Tech Coloproctol. 2001;5:163–164.
  • Schnitt SJ, Antonioli DA, Goldman H. Massive mural edema in severe pseudomembranous colitis. Arch Pathol Lab Med. 1983;107(4):211–213.
  • Tonna I, Welsby PD. Pathogenesis and treatment of Clostridium difficile infection. Postgrad Med J. 2005;81(956):367–369.
  • Farooq PD, Urrunaga NH, Tang DM, von Rosenvinge EC. Pseudomembranous colitis. Dis Mon. 2015;61(5):181–206.
  • Sugiyama T, Mukai M, Yamashita R, et al. Experimental models of Clostridium difficile enterocolitis in gnotobiotic mice. Prog Clin Biol Res. 1985;181:203–206.
  • Kelly CP, Pothoulakis C, Vavva F, et al. Neutrophil recruitment in Clostridium difficile toxins. Antimicrob Agents Chemother. 1996;40(2):373–379.
  • Abrams GD, Allo M, Rifkin GD, et al. Mucosal damage mediated by clostridial toxin in experimental clindamycin-associated colitis. Gut. 1980;21(6):493–499.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.